Anderson, Annie S.
Martin, Richard M. http://orcid.org/0000-0002-7992-7719
Renehan, Andrew G.
Cade, Janet
Copson, Ellen R. http://orcid.org/0000-0001-8994-4056
Cross, Amanda J.
Grimmett, Chloe
Keaver, Laura
King, Angela
Riboli, Elio
Shaw, Clare http://orcid.org/0000-0003-4169-9391
Saxton, John M. http://orcid.org/0000-0003-1945-9455
Anderson, Annie
Beeken, Rebecca
Cade, Janet
Cross, Amanda
King, Angela
Martin, Richard
Mitrou, Giota
Riboli, Elio
Saxton, John
Renehan, Andrew
,
Article History
Received: 28 April 2020
Revised: 24 September 2020
Accepted: 22 October 2020
First Online: 25 November 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Not applicable.
: R.M.M. reports grants from CRUK, during the conduct of the study. J.C. reports that she is the director of Dietary Assessment Ltd. E.R.C. reports other from SECA, personal fees from Roche, personal fees from Lilly, personal fees from Pfizer, personal fees from Novartis, personal fees from Astra-Zeneca and personal fees from Nanostring, outside the submitted work. C.S. reports personal fees from Boehringer Ingelheim, personal fees from Eli Lilley and Company and personal fees from Chugai, outside the submitted work. The remaining authors declare no competing interests.
: This work was supported by the NIHR Cancer and Nutrition Collaboration. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care Funding. R.M.M. is supported by a Cancer Research UK programme grant (C18281/A19169) and by the National Institute for Health Research (NIHR) Bristol Biomedical Research Centre. The National Institute for Health Research (NIHR) Bristol Biomedical Research Centre is funded by the National Institute for Health Research and is a partnership between University Hospitals Bristol NHS Trust and the University of Bristol. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. A.G.R. is supported by the Manchester NIHR Biomedical Research Centre (IS-BRC-1215-20007). C.S. is partly funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at The Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, London.